Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial resultsKelly C. Goldsmith, Yaël P. Mossé, Yueh‐Yun Chi et al.|Nature Medicine|2023Cited by 125
Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation statusCynthia Winter, John M. Maris, Bruce Pawel et al.|Pediatric Blood & Cancer|2008Cited by 48